يعرض 1 - 10 نتائج من 31 نتيجة بحث عن '"MESH: Streptococcal Infections"', وقت الاستعلام: 2.13s تنقيح النتائج
  1. 1

    المساهمون: Institute of Microbiology and Immunology [Belgrade, Serbia] (School of Medicine), University of Belgrade [Belgrade], National Reference Laboratory for Streptococci, Medical Faculty, University of Belgrade, Service de Bactériologie [CHU Cochin, AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre national de Référence des Streptocoques (CNR), DHU Risques Et Grossesse, Centre National de la Recherche Scientifique (CNRS)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris Descartes - Paris 5 (UPD5), Barrières et Pathogènes, [Institut Cochin] Departement Infection, immunité, inflammation, Institut Cochin (IC UM3 (UMR 8104 / U1016)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut Cochin (IC UM3 (UMR 8104 / U1016)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Biologie des Bactéries pathogènes à Gram-positif, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), This study was supported by the Federation of European Microbiological Societies [FEMS-RG-2014-0025.R1] and the SerbianMinistry of Education and Science [Project No175039]., BOUYSSIE, Reine, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: International Journal of Medical Microbiology
    International Journal of Medical Microbiology, Elsevier, 2019, 309 (1), pp.19-25. ⟨10.1016/j.ijmm.2018.10.005⟩
    International Journal of Medical Microbiology, 2019, 309 (1), pp.19-25. ⟨10.1016/j.ijmm.2018.10.005⟩

    وصف الملف: application/pdf

  2. 2

    المساهمون: Elie Metchnikoff Laboratory, University of Messina, University of Pavia, Centro Neurolesi Bonino Pulejo Messina (IRCCS Messina), Biologie des Bactéries pathogènes à Gram-positif - Biology of Gram-Positive Pathogens, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Scylla Biotech [Messina], Work described here was supported in part by funds granted to Scylla Biotech Srl by the Ministero dell’Università e della Ricerca Scientifica of Italy (Project n.4/13 ex art. 11 D.M. n. 593)., Università degli Studi di Pavia = University of Pavia (UNIPV), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Molecular Microbiology
    Molecular Microbiology, Wiley, 2018, 110 (1), pp.82-94. ⟨10.1111/mmi.14084⟩
    Molecular Microbiology, 2018, 110 (1), pp.82-94. ⟨10.1111/mmi.14084⟩

  3. 3

    المساهمون: Virulence bactérienne et maladies infectieuses (VBMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre d'Investigation Clinique [Bron] (CIC1407), Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Groupement Hospitalier Est [Bron], Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Salvy-Córdoba, Nathalie

    المصدر: PLoS ONE, Vol 16, Iss 3, p e0248231 (2021)
    PLoS ONE
    PLoS ONE, Public Library of Science, 2021, 16 (3), pp.e0248231. ⟨10.1371/journal.pone.0248231⟩

    مصطلحات موضوعية: Male, medicine.medical_treatment, Antibiotics, medicine.disease_cause, Hospitals, University, Medical Conditions, Endocrinology, MESH: Streptococcal Infections, Skeletal Joints, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Medicine and Health Sciences, Streptococcus Agalactiae, Oral Administration, Musculoskeletal System, Pathology and laboratory medicine, Routes of Administration, MESH: Treatment Outcome, MESH: Aged, Polymicrobial Infections, [SDV.MHEP.RSOA] Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, Prosthetics, MESH: Middle Aged, Multidisciplinary, Feet, MESH: Bone and Bones, Middle Aged, Medical microbiology, Anti-Bacterial Agents, Treatment Outcome, Infectious Diseases, [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, Staphylococcus aureus, Group B streptococci, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Engineering and Technology, Legs, Medicine, Vancomycin, Female, France, Pathogens, Anatomy, Research Article, Biotechnology, medicine.drug, medicine.medical_specialty, Endocrine Disorders, medicine.drug_class, Science, Prosthetic Device Infections, Bioengineering, Microbiology, Bone and Bones, MESH: Anti-Bacterial Agents, Streptococcal Infections, Internal medicine, Diabetes Mellitus, medicine, Humans, Internal fixation, Skeleton, Aged, Retrospective Studies, MESH: Hospitals, University, Pharmacology, MESH: Humans, Biology and life sciences, Bacteria, business.industry, Osteomyelitis, Organisms, Streptococcus, MESH: Retrospective Studies, medicine.disease, MESH: Streptococcus agalactiae, Comorbidity, MESH: Male, Microbial pathogens, MESH: France, Assistive Technologies, Streptococcus agalactiae, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Metabolic Disorders, Body Limbs, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Bacterial pathogens, Medical Devices and Equipment, Septic arthritis, business, MESH: Female

    وصف الملف: application/pdf

  4. 4

    المساهمون: CHU Lille, CNRS, Inserm, Institut Pasteur de Lille, Université de Lille, Centre Hospitalier Régional Universitaire [Lille] [CHRU Lille], METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS], Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 [CIIL], Centre Hospitalier de Roubaix, Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre Hospitalier de Tourcoing, Centre de Référence des Infections Ostéo-Articulaires Complexes Nord-Ouest (CRIOAC-Lille-Tourcoing), Hôpital Roger Salengro [Lille]-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre Hospitalier Gustave Dron [Tourcoing], Dr. Duployez works as a microbiological fellow in the microbiology department of the University Hospital of Lille, We thank the staff of the Centre National de Référence des Streptocoques and C. Poyart for their assistance in characterization of the group A streptococcal isolates., National Institute for Health Research, Université de Lille, LillOA

    المصدر: Emerging Infectious Diseases, Vol 24, Iss 11, Pp 2133-2134 (2018)
    Emerging Infectious Diseases
    Emerging Infectious Diseases, 2017, 23 (10), pp.1745-1746. ⟨10.3201/eid2310.170343⟩
    Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2017, 23 (10), pp.1745-1746. ⟨10.3201/eid2310.170343⟩
    Emerging Infectious Diseases, Vol 23, Iss 10, Pp 1745-1746 (2017)

    مصطلحات موضوعية: Male, Letter, Epidemiology, medicine.medical_treatment, Streptococcal infections, MESH: Streptococcal Infections/drug therapy, MESH: Streptococcal Infections/microbiology, 0302 clinical medicine, 1108 Medical Microbiology, MESH: Fasciitis, Necrotizing/drug therapy, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, MESH: Streptococcus pyogenes/growth & development, Medicine, MESH: Anti-Bacterial Agents/therapeutic use, Streptococcus, Group A Streptococcus, familial, Streptococci, 3. Good health, 1117 Public Health And Health Services, Microbiology (medical), medicine.medical_specialty, amoxicillin-clavulanic acid, MESH: Amoxicillin-Potassium Clavulanate Combination/therapeutic use, 030106 microbiology, MESH: Bursitis/pathology, MESH: Disease Transmission, Infectious, Amoxicillin-Potassium Clavulanate Combination, Microbiology, lcsh:Infectious and parasitic diseases, 03 medical and health sciences, Research Letter, Disease Transmission, Infectious, MESH: Streptococcal Infections/transmission, Humans, Fasciitis, Necrotizing, Post-exposure prophylaxis, Spouses, MESH: Streptococcal Infections/pathology, Aged, MESH: Humans, Bacteria, Public health, lcsh:R, Familial transmission, antibacterial, polymorphonuclear, chemistry, Immunology, Linezolid, invasive, MESH: Female, 0301 basic medicine, Pediatrics, NSAIDs, Familial Transmission of emm12 Group A Streptococcus, MESH: Fasciitis, Necrotizing/pathology, lcsh:Medicine, medicine.disease_cause, Group A, chemistry.chemical_compound, antibiotic, 030212 general & internal medicine, MESH: Aged, MESH: Fasciitis, Necrotizing/microbiology, MESH: Streptococcus pyogenes/pathogenicity, Transmission (medicine), Incidence (epidemiology), Anti-Inflammatory Agents, Non-Steroidal, Anti-Bacterial Agents, Infectious Diseases, MESH: Bursitis/microbiology, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, MESH: Streptococcus pyogenes/drug effects, Female, iGAS, group A streptococcal infections, leukocyte, STREPTOCOCCAL INFECTIONS, procalcitonin, medicine.drug, MESH: Contraindications, Drug, Streptococcus pyogenes, MESH: Anti-Inflammatory Agents, Non-Steroidal/adverse effects, Secondary infection, linezolid, C-reactive, emm12, Bursitis, 030225 pediatrics, MESH: Spouses, antimicrobial drug, lcsh:RC109-216, Letters to the Editor, nonsteroidal anti-inflammatory drugs, Amoxicillin/clavulanic acid, business.industry, Contraindications, Drug, 1103 Clinical Sciences, MESH: Male, MESH: Bursitis/drug therapy, business

    وصف الملف: application/octet-stream; application/rdf+xml; charset=utf-8; application/pdf

  5. 5

    المساهمون: University Hospitals Leuven [Leuven], Antwerp University Hospital [Edegem] (UZA), Ecologie et Evolution de la Résistance aux Antibiotiques / Ecology and Evolution of Antibiotics Resistance (EERA), Institut Pasteur [Paris]-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris] (IP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Pediatric Infectious Disease Journal
    Pediatric Infectious Disease Journal, Lippincott, Williams & Wilkins, 2016, 35 (11), pp.1272-1275. ⟨10.1097/INF.0000000000001290⟩
    Pediatric Infectious Disease Journal, 2016, 35 (11), pp.1272-1275. ⟨10.1097/INF.0000000000001290⟩
    The pediatric infectious disease journal

  6. 6

    المساهمون: Biologie des Bactéries pathogènes à Gram-positif - Biology of Gram-Positive Pathogens (BBPG+), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Barrières et Pathogènes, [Institut Cochin] Departement Infection, immunité, inflammation, Institut Cochin (IC UM3 (UMR 8104 / U1016)), Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Cochin (IC UM3 (UMR 8104 / U1016)), Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre national de Référence des Streptocoques (CNR), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), This work was supported by the DIM Malinf from the Conseil Régional d’Ile-de-France (Grant DIM130065) to CP and SD and the French Government's Investissement d’Avenir program, Laboratoire d’Excellence 'Integrative Biology of Emerging Infectious Diseases' Grant ANR-10-LABX-62-IBEID. NS was recipient of a doctoral fellowship from the DIM Malinf., ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut Cochin (IC UM3 (UMR 8104 / U1016)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Microbes and Infection
    Microbes and Infection, Elsevier, 2019, 21 (2), pp.99-103. ⟨10.1016/j.micinf.2018.10.004⟩
    Microbes and Infection, 2019, 21 (2), pp.99-103. ⟨10.1016/j.micinf.2018.10.004⟩

  7. 7

    المساهمون: Inserm, Université de Lille, CHU Lille, Service des maladies infectieuses et tropicales [Rouen], Lille Inflammation Research International Center - U 995 [LIRIC], Centre Hospitalier Gustave Dron [Tourcoing], Hospital General Universitario 'Gregorio Marañón' [Madrid], CHU Amiens-Picardie, CHU Rouen, Université de Rouen Normandie [UNIROUEN], Université de Caen Normandie [UNICAEN], Université de Picardie Jules Verne [UPJV], Marrow Adiposity & Bone Lab - Adiposité Médullaire et Os - ULR 4490 [MABLab (ex-pmoi)], Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS], Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Service de Microbiologie [Lille], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Université de Rouen Normandie (UNIROUEN), Université de Caen Normandie (UNICAEN), Université de Picardie Jules Verne (UPJV), Marrow Adiposity & Bone Lab - Adiposité Médullaire et Os - ULR 4490 (MABLab (ex-pmoi)), Université du Littoral Côte d'Opale (ULCO)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Thanks to Mr Philippe Choisy for technical assistance. J.L-T was supported by a grant from the Instituto de Salud Carlos III (Ministry of Economy and Competitiveness, Government of Spain, CD14/00176) and to Sharon Calandra for english editing., G4 bone and joint infection study group (G4BJIS)., Université de Lille, LillOA

    المصدر: BMC Infectious Diseases
    BMC Infectious Diseases, 2016, 16, pp.568. ⟨10.1186/s12879-016-1889-0⟩
    BMC Infectious Diseases, BioMed Central, 2016, 16, pp.568. ⟨10.1186/s12879-016-1889-0⟩

    مصطلحات موضوعية: Male, 0301 basic medicine, Prosthetic joint infection, Knee Joint, Levofloxacin, Medical microbiology, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Mesh:Treatment Outcome, Mesh:Knee Prosthesis/adverse effects, Mesh:Humans, Mesh:Knee Joint/microbiology, Mesh:Middle Aged, Mesh:Streptococcal Infections/etiology, Mesh:Anti-Bacterial Agents/administration & dosage, Mesh:Arthritis/drug therapy, Mesh:Hip Prosthesis/microbiology, Mesh:Prosthesis-Related Infections/drug therapy, Mesh:Female, Mesh:Knee Joint/surgery, Mesh:Rifampin/administration & dosage, Mesh:Male, Mesh:Streptococcal Infections/drug therapy, Mesh:Aged, Mesh:Levofloxacin/administration & dosage, Mesh:Drug Therapy, Mesh:Combination, Mesh:Arthroplasty, Mesh:Replacement, Mesh:Knee/adverse effects, Mesh:Prosthesis-Related Infections/diagnosis, Mesh:80 and over, Mesh:Retrospective Studies, Mesh:Hip Prosthesis/adverse effects, Mesh:Knee Prosthesis/microbiology, Outcome, Rifampicin, Streptococcus spp, Risk factors, Arthroplasty, Replacement, Knee, 10. No inequality, Aged, 80 and over, Middle Aged, Anti-Bacterial Agents, 3. Good health, Treatment Outcome, Infectious Diseases, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Drug Therapy, Combination, Female, Rifampin, Knee Prosthesis, Research Article, medicine.drug, musculoskeletal diseases, medicine.medical_specialty, Prosthesis-Related Infections, Prosthetic joint, 030106 microbiology, 03 medical and health sciences, Streptococcal Infections, medicine, Humans, Aged, Retrospective Studies, business.industry, Arthritis, Surgery, stomatognathic diseases, Tropical medicine, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Hip Prosthesis, business

    وصف الملف: application/octet-stream; application/rdf+xml; charset=utf-8; application/pdf

  8. 8

    المساهمون: Repositório Científico do Instituto Politécnico do Porto, Instituto de Investigação e Inovação em Saúde, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto = University of Porto, Instituto de Investigação e Inovação em Saúde (I3S), Instituto de Biologia Molecular e Celular - institute for molecular and cell biology [Porto, Portugal] (IBMC), Instituto Politécnico do Porto = Polytechnic Institute of Porto, Instituto de Biologia Molecular e Celular (IBMC), Life and Health Sciences Research Institute [Braga] (ICVS), University of Minho [Braga], Karolinska Institutet [Stockholm], Biologie des Bactéries pathogènes à Gram-positif - Biology of Gram-Positive Pathogens, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), This work was supported by funds from Foundation for Science and Technology (FCT), European Regional Development Fund (FEDER) and Compete under project POCI-01-0145-FEDER-016607 (PTDC/IMI-MIC/1049/2014) and from the project NORTE-01-0145-FEDER-000012, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). T.S. and A.M. were supported by Investigador FCT (IF/00875/2012 and IF/00753/2014), POPH and Fundo Social Europeu. E.B.A. and C.C.P. hold postdoctoral fellowships from FCT (PTDC/IMI-MIC/1049/2014 and SFRH/BPD/91962/2012). Ar.F. and P.T.C. were supported by Laboratoire d’Excellence (LABEX) Integrative Biology of Emerging Infectious Diseases (grant ANR-10-LABX-62-IBEID)., ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), Universidade do Porto, Instituto Politécnico do Porto = Oporto Polytechnic Institute, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Instituto de Ciências Biomédicas Abel Salazar, Universidade do Minho

    المصدر: Repositório Científico de Acesso Aberto de Portugal
    Repositório Científico de Acesso Aberto de Portugal (RCAAP)
    instacron:RCAAP
    Nature Communications
    Nature Communications, 2018, 9 (1), pp.3138. ⟨10.1038/s41467-018-05492-y⟩
    Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
    Nature Communications, Nature Publishing Group, 2018, 9 (1), pp.3138. ⟨10.1038/s41467-018-05492-y⟩

    وصف الملف: application/pdf

  9. 9

    المساهمون: Department of Laboratory Medicine [Lund], Lund University [Lund], Défense innée et inflammation, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de pharmacologie moléculaire et cellulaire (IPMC), Centre National de la Recherche Scientifique (CNRS)-Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA), Department of Clinical Sciences [Lund], Work in the laboratory of T. A. was supported by the Swedish Government Funding for Clinical Research (12762), the Royal Physiographic Society in Lund, the Swedish Society of Medicine, and the trusts of Olle Engkvist Byggmästare, Anna and Edwin Berger, Emil and Wera Cornell, Crafoord, Ollie, and Elof Ericksson, Clas Groschinsky, Jane and Dan Olsson, Åke Wiberg, Alfred Österlund, and Gyllenstiernska Krapperupsstiftelsen. L. T. was supported by Institut Pasteur, Paris, and INSERM. G. L. was supported by CNRS and the Association pour la Recherche sur le Cancer. F. K. was supported by the Swedish Government Funding for Clinical Research., Wu, Yongzheng, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Nice Sophia Antipolis (1965 - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UCA)

    المصدر: Journal of Infectious Diseases
    Journal of Infectious Diseases, Oxford University Press (OUP), 2013, 208 (12), pp.2025-2035. ⟨10.1093/infdis/jit359⟩
    Journal of Infectious Diseases, 2013, 208 (12), pp.2025-2035. ⟨10.1093/infdis/jit359⟩

    مصطلحات موضوعية: Lung Diseases, Male, MESH: Streptococcal Infections / enzymology, medicine.disease_cause, Group B, MESH: Lung Diseases, Mice, 0302 clinical medicine, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, MESH: Streptococcal Infections / blood, Immunology and Allergy, MESH: Animals, Pathogen, innate immunity, reproductive and urinary physiology, MESH: Immunity, Innate / immunology, MESH: Aged, 0303 health sciences, MESH: Middle Aged, Streptococcus, MESH: Infant, Newborn, MESH: Antimicrobial Cationic Peptides, MESH: Group II Phospholipases A2 / immunology, Middle Aged, 3. Good health, Anti-Bacterial Agents, Infectious Diseases, Acute Disease, Host-Pathogen Interactions, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, MESH: Acute Disease, Female, medicine.symptom, MESH: Streptococcus agalactiae / pathogenicity, group B streptococcus, Adult, MESH: Group II Phospholipases A2 / genetics, MESH: Mice, Transgenic, Antimicrobial peptides, Inflammation, Mice, Transgenic, MESH: Anti-Bacterial Agents / pharmacology, Biology, Group II Phospholipases A2, Microbiology, Streptococcus agalactiae, Sepsis, 03 medical and health sciences, MESH: Streptococcal Infections / microbiology, bactericidal, Streptococcal Infections, medicine, Animals, Humans, MESH: Mice, MESH: Streptococcus agalactiae / immunology, 030304 developmental biology, Aged, MESH: Group II Phospholipases A2 / blood, Innate immune system, MESH: Humans, MESH: Host-Pathogen Interactions, Infant, Newborn, MESH: Adult, medicine.disease, bacterial infections and mycoses, [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology, MESH: Male, Immunity, Innate, antimicrobial molecules, Pneumonia, Immunology, bacteria, [SDV.MP.BAC] Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology, MESH: Female, 030215 immunology, Antimicrobial Cationic Peptides

  10. 10

    المساهمون: Recherche Epidémiologique en Santé Périnatale et Santé des Femmes et des Enfants (UMR_S 953), Université Paris-Sud - Paris 11 (UP11)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Pédiatrie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-PRES Sorbonne Paris Cité-CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Etudes cliniques et épidémiologiques, la recherche diagnostique et thérapeutique en pathologie pédiatrique, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Robert Debré-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Association Clinique Thérapeutique Infantile du Val de Marne (ACTIV), Service de Microbiologie [Créteil], CHI Créteil, AP-HP Hôpital universitaire Robert-Debré [Paris], Centre de Recherche Clinique [Créteil] (CRC), Centre Hospitalier Intercommunal de Créteil (CHIC), Association Française de P ediatrie Ambulatoire (AFPA), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-CH de Troyes, Recherche Epidémiologique en Santé Périnatale et Santé des Femmes et des Enfants ( UMR_S 953 ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Université Paris-Sud - Paris 11 ( UP11 ), Assistance publique - Hôpitaux de Paris (AP-HP)-Université Paris Descartes - Paris 5 ( UPD5 ) -PRES Sorbonne Paris Cité-CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Robert Debré-Hôpital Européen Georges Pompidou [APHP] ( HEGP ) -Association Clinique Thérapeutique Infantile du Val de Marne (ACTIV), Service de Microbiologie [R Debré], Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Robert Debré-Université Paris Diderot - Paris 7 ( UPD7 ) -PRES Sorbonne Paris Cité, Centre de Recherche Clinique ( CRC ), Association Française de P ediatrie Ambulatoire ( AFPA ), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand ( CHU Dijon ) -CH de Troyes, Debs, Nayla

    المصدر: J Pediatr
    J Pediatr, 2013, 162 (6), pp.1282-4, 1284.e1. ⟨10.1016/j.jpeds.2013.01.050⟩
    J Pediatr, 2013, 162 (6), pp.1282-4, 1284.e1. 〈10.1016/j.jpeds.2013.01.050〉

    مصطلحات موضوعية: MESH : Streptococcal Infections, MESH: Pharynx, MESH : Child, Preschool, medicine.disease_cause, Polymerase Chain Reaction, Group A, law.invention, 0302 clinical medicine, MESH : Child, MESH: Streptococcal Infections, law, MESH: Child, MESH: Staphylococcus aureus, 030212 general & internal medicine, Child, MESH : Polymerase Chain Reaction, Polymerase chain reaction, Polymerase, 0303 health sciences, biology, MESH : Staphylococcus aureus, MESH : Antigens, Bacterial, [ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologie, Pharyngitis, MESH: Case-Control Studies, 3. Good health, Streptococcal pyrogenic exotoxin B, Staphylococcus aureus, Child, Preschool, MESH : Streptococcus pyogenes, MESH : Sensitivity and Specificity, medicine.symptom, Bacterial inhibition, MESH: Streptococcus pyogenes, psychological phenomena and processes, MESH : Case-Control Studies, Adolescent, Streptococcus pyogenes, MESH : Pharynx, Sensitivity and Specificity, Microbiology, 03 medical and health sciences, Antigen, MESH : Adolescent, Streptococcal Infections, mental disorders, medicine, Humans, False Positive Reactions, MESH: Adolescent, Antigens, Bacterial, MESH: Humans, MESH: False Positive Reactions, 030306 microbiology, business.industry, MESH: Pharyngitis, MESH : Humans, MESH : Pharyngitis, MESH: Child, Preschool, MESH: Polymerase Chain Reaction, Virology, MESH: Sensitivity and Specificity, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Case-Control Studies, MESH : False Positive Reactions, Pediatrics, Perinatology and Child Health, biology.protein, Pharynx, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, MESH: Antigens, Bacterial

    وصف الملف: application/pdf